| Mrs Jessica Anne Henry, ARNP | |
|
1700 Geary St Se, Albany, OR 97322-6842 | |
| (541) 812-5500 | |
| Not Available |
| Full Name | Mrs Jessica Anne Henry |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 1700 Geary St Se, Albany, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053658617 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | ARNP9246608 (Florida) | Secondary |
| 363L00000X | Nurse Practitioner | 202114821NP-PP (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shi Keys Llc | 2163835513 | 17 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
| Entity Name | Adventist Health System/sunbelt, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073565610 PECOS PAC ID: 6406849256 Enrollment ID: O20040406001849 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
| Entity Name | Paragon Contracting Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225071459 PECOS PAC ID: 3971417825 Enrollment ID: O20041207001148 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
| Entity Name | Criticare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003148024 PECOS PAC ID: 7315133543 Enrollment ID: O20101130000293 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
| Entity Name | Shi Keys Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952903536 PECOS PAC ID: 2163835513 Enrollment ID: O20210105000345 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Jessica Anne Henry, ARNP Po Box 1188, Corvallis, OR 97339-1188 Ph: () - | Mrs Jessica Anne Henry, ARNP 1700 Geary St Se, Albany, OR 97322-6842 Ph: (541) 812-5500 |
News Archive
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
Xcellerex, Inc. announced today that it has begun construction of a state-of-the-art cGMP FlexFactory® biomanufacturing facility at its headquarters location in Marlborough, Massachusetts. Construction will be completed in September 2010. The facility, the second FlexFactory at the company's headquarters site, will expand Xcellerex's capacity to provide bridge biomanufacturing services for clients that are planning or building their own FlexFactory facilities. The plant will also support Xcellerex's contract manufacturing operations.
Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.
A new study has found that long term or continued use of acetaminophen or paracetamol during pregnancy is linked to a doubled risk of attention-deficit hyperactivity disorder (ADHD) in children. The study entitled, "Prenatal Exposure to Acetaminophen and Risk of ADHD" was published in the latest issue of the journal Pediatrics.
Mexican American children are experiencing substantial burdens of obesity, pre-diabetes, and other health problems which historically would have been expected to develop much later in life. The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
› Verified 5 days ago
Huei Ling Tsai, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2832 Weather Stone St Nw # Na, Albany, OR 97321 Phone: 415-619-4332 | |
Ms. Virginia J Taylor, CFNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1100 7th Ave Sw, Albany, OR 97321 Phone: 541-812-4980 Fax: 541-926-9329 | |
Ms. Jennifer Marie Wilson, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1700 Geary St Se, Albany, OR 97322 Phone: 541-812-5500 | |
Susan Parker, RN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1005 Springhill Dr. Nw, Albany, OR 97321 Phone: 541-967-4518 | |
Mrs. Yvonne Elaine Keep, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1705 Waverly Dr Se, Albany, OR 97322 Phone: 541-967-8221 | |
Jonell Blase, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1100 7th Ave Sw, Albany, OR 97321 Phone: 541-812-5600 |